RxDoctor Payments Data

James Laster, APRN

Psychiatric/Mental Health · Tulsa, OKNPI 1437563590

Payments from drug & device makers

$301in general payments, 2019–2025

Across 16 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$112
  • Sunovion Pharmaceuticals Inc.$77
  • AbbVie$42
  • Lundbeck LLC$20
  • Johnson & Johnson$18
  • Takeda Pharmaceuticals U.S.A., Inc.$16
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$301100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$301 in reported general payments places this provider in the 30th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma

Medicare billing

Part B allowed, 2024
$57,095
Medicare patients
226
Services billed
557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole27$46,210
VraylarCariprazine Hcl22$30,410
Invega SustennaPaliperidone Palmitate14$28,782
Duloxetine Hcl424$11,856
Bupropion XlBupropion Hcl321$8,003
Buspirone Hcl360$7,045
Desvenlafaxine Succinate ErDesvenlafaxine Succinate43$5,961
Trazodone Hcl435$5,707
Mirtazapine362$5,039
Venlafaxine Hcl ErVenlafaxine Hcl223$4,739
Quetiapine Fumarate267$4,713
Aripiprazole150$4,571
Doxepin Hcl39$4,542
Fluoxetine Hcl177$3,673
Divalproex Sodium ErDivalproex Sodium47$3,282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$112$46,21027 claims
AbbVieVraylar$42$30,41022 claims
Johnson & JohnsonInvega Sustenna$18$28,78214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 231 psychiatric/mental health providers in Oklahoma.

Other psychiatric/mental health in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →